Zmijewski Michal A, Li Wei, Zjawiony Jordan K, Sweatman Trevor W, Chen Jianjun, Miller Duane D, Slominski Andrzej T
Department of Pathology and Laboratory Medicine and the Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Photochem Photobiol Sci. 2008 Dec;7(12):1570-6. doi: 10.1039/b809005j. Epub 2008 Sep 4.
Calcitriol (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-1alpha,3beta,25-triol) is a powerful oncostatic form of vitamin D3 that is of limited clinical utility due to hypercalcemic (toxic) effects. Since the removal of the side chain reduces or eliminates the calcemic activity of vitamin D3, secosteroidal compounds lacking or with a shortened side chain are good candidates for anti-cancer drugs. In addition, 5,7-steroidal dienes without a side chain can be generated in vivo under pathological conditions. A series of androsta- and pregna-5,7-dienes was efficiently synthesized from their respective 3-acetylated 5-en precursors by bromination-dehydrobromination and deacetylation reactions. Ultraviolet B (UVB) irradiation was used to generate corresponding 9,10-secosteroids with vitamin D-like structures. Additional products with tachysterol-like (T-like) structures or 5,7-dienes with inverted configuration at C-9 and C-10 (lumisterol, L-like) were also detected. Different doses of UVB resulted in formation of various products. At low doses, previtamin D-, T- or L-like compounds were formed as the main products, while higher doses induced further isomerization, with formation of potentially oxidized derivatives. In summary, we describe dynamic UVB induced conversion of androsta- and pregna-5,7-dienes into vitamin D-like compounds and their rearranged analogues; additionally novel T-like and L-like structures were also produced and characterized. Further biological evaluation of newly synthesized compounds should help to select the best candidate(s) for potential treatment of hyperproliferative diseases including cancer.
骨化三醇((3β,5Z,7E)-9,10-开环胆甾-5,7,10(19)-三烯-1α,3β,25-三醇)是维生素D3的一种强效抑癌形式,但由于其高钙血症(毒性)作用,临床应用有限。由于去除侧链会降低或消除维生素D3的血钙活性,因此缺乏侧链或侧链缩短的甾类化合物是抗癌药物的良好候选物。此外,在病理条件下,体内可生成无侧链的5,7-甾二烯。通过溴化-脱溴化和脱乙酰化反应,从各自的3-乙酰化5-烯前体高效合成了一系列雄甾-5,7-二烯和孕甾-5,7-二烯。使用紫外线B(UVB)照射生成具有维生素D样结构的相应9,10-开环甾类化合物。还检测到了具有速甾醇样(T样)结构或在C-9和C-10处具有反向构型的5,7-二烯(光甾醇,L样)额外产物。不同剂量的UVB导致形成各种产物。在低剂量下,维生素D原、T样或L样化合物作为主要产物形成,而较高剂量则诱导进一步异构化,形成潜在的氧化衍生物。总之,我们描述了UVB动态诱导雄甾-5,7-二烯和孕甾-5,7-二烯转化为维生素D样化合物及其重排类似物;此外,还产生并表征了新型T样和L样结构。对新合成化合物的进一步生物学评估应有助于选择用于潜在治疗包括癌症在内的过度增殖性疾病的最佳候选物。